Area of research
Hematology · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Medicine, Pharmacology, Ponatinib, Myeloid leukemia, Proarrhythmia, and Drug.
Abstract LB077: Reengineering ponatinib to minimize cardiovascular toxicity
Abstract P2109: Elaborating Safety Margins To Predict Drug Proarrhythmia Using Deep Learning And Patient-derived IPSCs.
Abstract P3105: Improving Cardiovascular Toxicity Of Chronic Myeloid Leukemia Therapy.
Abstract 15594: Decreasing the High Risk of Ponatinib-Induced Cardiovascular Toxicity in Chronic Myeloid Leukemia
Unfolded Protein Response as a Compensatory Mechanism and Potential Therapeutic Target in PLN R14del Cardiomyopathy
Abstract 14393: Deep Learning and Patient-Derived hiPSC Cardiomyocytes to Predict Drug Proarrhythmia
Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes